c.i. 42510 has been researched along with kainic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lees, GJ | 1 |
| Schmandt, G; Schmidt, KF | 1 |
| Baluchnejadmojarad, T; Barati, H; Goudarzi, M; Jamali-Raeufy, N; Roghani, M | 1 |
3 other study(ies) available for c.i. 42510 and kainic acid
| Article | Year |
|---|---|
In vivo and in vitro staining of acidophilic neurons as indicative of cell death following kainic acid-induced lesions in rat brain.
Topics: Animals; Brain; Histological Techniques; Kainic Acid; Male; Rats; Rats, Inbred Strains; Rosaniline Dyes; Staining and Labeling; Trypan Blue | 1989 |
Measurement of concentration-response relationships by concentration-ramp application of agonists.
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; Excitatory Amino Acid Agonists; Glutamic Acid; In Vitro Techniques; Ion Channel Gating; Kainic Acid; Membrane Potentials; Perches; Phosphorylation; Retina; Rosaniline Dyes; Spectrophotometry, Atomic | 1999 |
Combination therapy with dipeptidyl peptidase-4 and P2X7 purinoceptor inhibitors gives rise to antiepileptic effects in rats.
Topics: Animals; Anticonvulsants; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; DNA Fragmentation; Drug Therapy, Combination; Electroencephalography; Epilepsy; Gliosis; Hippocampus; Kainic Acid; Linagliptin; Male; Purinergic P2Y Receptor Antagonists; Rats; Rats, Wistar; Rosaniline Dyes; Seizures; Treatment Outcome | 2020 |